エルビテグラビル
↑ Gilead Press Release Gilead and Japan Tobacco Sign Licensing Agreement for Novel HIV Integrase Inhibitor March 22, 2008
↑ “Broad Anti-Retroviral Activity and Resistance Profile of a Novel Human Immunodeficiency Virus Integrase Inhibitor, Elvitegravir (JTK-303/GS-9137)”. J Virol 82 (2): 764–74. (2007). doi:10.1128/JVI.01534-07. PMC 2224569. PMID 17977962. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2224569/.
↑ Stellbrink HJ (2007). “Antiviral drugs in the treatment of AIDS: what is in the pipeline ?”. Eur. J. Med. Res. 12 (9): 483–95. PMID 17933730.
↑ Gilead Press Release Phase III Clinical Trial of Elvitegravir July 22, 2008
↑ Sax, P. E.; Dejesus, E.; Mills, A.; Zolopa, A.; Cohen, C.; Wohl, D.; Gallant, J.